The India livestock animal health market size was estimated at USD 1.73 billion in 2024 and is projected to reach USD 4.17 billion by 2033, growing at a CAGR of 10.23% from 2025 to 2033. The India livestock animal health market is continuously growing, driven by the region’s large and dense livestock population, increasing protein consumption, and the rising disease burden among production animals, prompting higher demand for vaccines, pharmaceuticals, and diagnostics to safeguard herd health and productivity.
In addition, growing government initiatives are driving market growth. For instance, in March 2025, the Union Cabinet approved a revised Livestock Health and Disease Control Programme (LHDCP) with a budget of INR 3,880 crore (USD 453 Mn) for 2024-25 and 2025-26. The revamped scheme consists of three core components: The National Animal Disease Control Programme (NADCP), Livestock Health & Disease Control (LH&DC), and the newly launched Pashu Aushadhi initiative. Key focus elements include mass vaccinations, deployment of mobile veterinary units, and distribution of affordable generic veterinary medicines through PM-Kisan Samriddhi Kendras (Centers) and cooperatives.
The India livestock animal health market is being propelled by a combination of rising disease prevention needs, technological innovations, and supportive government policies. A key growth driver is the increasing product innovation and launches, particularly in the poultry vaccine segment, aimed at tackling persistent and economically damaging diseases. For instance, in November 2024, Boehringer Ingelheim launched a next-generation vaccine targeting Marek’s disease in poultry, utilizing a novel serotype-1 construct and controlled attenuation technology to provide early, long-lasting immunity to vulnerable young birds. Similarly, in June 2025, the company introduced a single-dose, three-in-one poultry vaccine that protects against Bursal, Newcastle, and Marek’s diseases, streamlining hatchery vaccination programs, reducing labor costs, and minimizing handling stress, thus enhancing bird health and farm productivity.
Government-backed disease control programs and livestock infrastructure investments are further accelerating market growth. Initiatives such as the National Animal Disease Control Program (NADCP), with an outlay of INR 13,340 crore (USD 1.8 billion), aim to eradicate Foot and Mouth Disease (FMD) and Brucellosis by 2030, significantly boosting demand for vaccines, diagnostics, and veterinary services. Additionally, the Bharat Pashudhan Data Stack, launched in March 2024, has registered over 15.5 crore animals and enables real-time tracking of vaccinations, artificial inseminations, and disease outbreaks, improving traceability and health monitoring.
Private sector expansion and strategic collaborations also shape the market's growth trajectory. For example, in February 2025, Biovet, part of Bharat Biotech Group, received CDSCO approval for BIOLUMPIVAXIN, the first global DIVA marker vaccine for Lumpy Skin Disease in dairy cattle and buffaloes, with a production capacity of 500 million doses annually. Such innovations, coupled with increasing partnerships between global animal health leaders and Indian firms, enable advanced solutions to reach rural and peri-urban livestock farmers, strengthening India’s livestock productivity and health outcomes.
This product will be delivered within 2 business days.
In addition, growing government initiatives are driving market growth. For instance, in March 2025, the Union Cabinet approved a revised Livestock Health and Disease Control Programme (LHDCP) with a budget of INR 3,880 crore (USD 453 Mn) for 2024-25 and 2025-26. The revamped scheme consists of three core components: The National Animal Disease Control Programme (NADCP), Livestock Health & Disease Control (LH&DC), and the newly launched Pashu Aushadhi initiative. Key focus elements include mass vaccinations, deployment of mobile veterinary units, and distribution of affordable generic veterinary medicines through PM-Kisan Samriddhi Kendras (Centers) and cooperatives.
The India livestock animal health market is being propelled by a combination of rising disease prevention needs, technological innovations, and supportive government policies. A key growth driver is the increasing product innovation and launches, particularly in the poultry vaccine segment, aimed at tackling persistent and economically damaging diseases. For instance, in November 2024, Boehringer Ingelheim launched a next-generation vaccine targeting Marek’s disease in poultry, utilizing a novel serotype-1 construct and controlled attenuation technology to provide early, long-lasting immunity to vulnerable young birds. Similarly, in June 2025, the company introduced a single-dose, three-in-one poultry vaccine that protects against Bursal, Newcastle, and Marek’s diseases, streamlining hatchery vaccination programs, reducing labor costs, and minimizing handling stress, thus enhancing bird health and farm productivity.
Government-backed disease control programs and livestock infrastructure investments are further accelerating market growth. Initiatives such as the National Animal Disease Control Program (NADCP), with an outlay of INR 13,340 crore (USD 1.8 billion), aim to eradicate Foot and Mouth Disease (FMD) and Brucellosis by 2030, significantly boosting demand for vaccines, diagnostics, and veterinary services. Additionally, the Bharat Pashudhan Data Stack, launched in March 2024, has registered over 15.5 crore animals and enables real-time tracking of vaccinations, artificial inseminations, and disease outbreaks, improving traceability and health monitoring.
Private sector expansion and strategic collaborations also shape the market's growth trajectory. For example, in February 2025, Biovet, part of Bharat Biotech Group, received CDSCO approval for BIOLUMPIVAXIN, the first global DIVA marker vaccine for Lumpy Skin Disease in dairy cattle and buffaloes, with a production capacity of 500 million doses annually. Such innovations, coupled with increasing partnerships between global animal health leaders and Indian firms, enable advanced solutions to reach rural and peri-urban livestock farmers, strengthening India’s livestock productivity and health outcomes.
India Livestock Animal Market Report Segmentation
This report forecasts revenue growth provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the India livestock animal health market report based on animal type, and product:Product Outlook (Revenue, USD Million, 2021-2033)
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents, and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
Animal Type Outlook (Revenue, USD Million, 2021-2033)
- Poultry
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Antimicrobials
- Anti-infectives except Antimicrobial
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents, and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Anticoccidials
- Pre/Probiotics & Phytotherapeutics
- Performance enhancers (AGP)
- Other
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Swine
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Immunocastration
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Endectocides
- Other Parasiticides
- Anti-infectives
- Antimicrobials
- Anti-infectives except Antimicrobial
- Anti-inflammatory
- Analgesics
- Hormone Products
- Others
- Diagnostics
- Consumables, reagents, and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Anticoccidials
- Performance enhancers (Probiotics + Phytogenics + Others Additives (β-adrenergic agonist)
- Other
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Cattle
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Artificial Insemination Products (Semen)
- Reproductive Disease Biologics
- Respiratory Disease Biologics
- Other Biologics except AI
- Pharmaceuticals
- Parasiticides
- Ectoparasiticides
- Endoparasiticides
- Endectocides
- Anti-infectives
- Antimicrobials
- Anti-infectives except Antimicrobial
- Anti-inflammatory
- Analgesics
- Hormone Products
- Others
- Diagnostics
- Consumables, reagents, and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Oral MFAs
- Injectable MFAs
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Sheep & Goat
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents, and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
- Fish
- Biologics
- Vaccines
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
- Other Biologics
- Pharmaceuticals
- Parasiticides
- Anti-infectives
- Anti-inflammatory
- Analgesics
- Others
- Diagnostics
- Consumables, reagents, and kits
- Instruments and devices
- Equipment & Disposables
- Critical Care Consumables
- Anesthesia Equipment
- Fluid Management Equipment
- Temperature Management Equipment
- Rescue & Resuscitation Equipment
- Research Equipment
- Patient Monitoring Equipment
- Medicinal Feed Additives
- Others
- Veterinary Telehealth
- Veterinary Software
- Livestock Monitoring
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. India Livestock Animal Health Market Variable Trends & Scope
Chapter 4. India Livestock Animal Health Market: Animal Type Estimates & Trend Analysis
Chapter 5. India Livestock Animal Health Market: Product Estimates & Trend Analysis
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this India Livestock Animal Health market report include:- Boehringer Ingelheim International GmbH
- Zoetis
- IDEXX Laboratories, Inc.
- Merck & Co., Inc.
- Elanco
- Hester Biosciences Limited
- Ceva Santé Animale
- Phibro Animal Health Corporation
- Virbac
- Dechra Pharmaceuticals Plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | August 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 1.73 Billion |
| Forecasted Market Value ( USD | $ 4.17 Billion |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | India |
| No. of Companies Mentioned | 11 |
